Laura Randa

Laura Randa oversees Market Access, Health Economics and Outcomes Research, Trade and Public Policy for the company. She has more than 22 years in market access, policy, specialty pharmacy and trade to deliver profitability through strategic planning and execution. She has launched 31 products in diverse disease categories. Ms. Randa joins us after serving as Vice President, National Accounts at Novartis, where she led the National Account Team and a cross-functional team driving business in payer sales, marketing, medical affairs and finance. In her previous role as Head of Payer Engagement at Regeneron, Ms. Randa transformed how the company launches and markets products and drove the market access commercialization strategy that led to the success of its atopic dermatitis therapy, Dupixent®.

Ms. Randa earned a BS in International Economics and Education from Ohio State University and an MBA with a concentration in healthcare from the University of Delaware.